Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease

Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease

Bibliographic Details
Main Authors:	Kim, Changyoun, Ojo-Amaize, Emmanuel, Spencer, Brian, Rockenstein, Edward, Mante, Michael, Desplats, Paula, Wrasidlo, Wolf, Adame, Anthony, Nchekwube, Emeka, Oyemade, Olusola, Okogun, Joseph, Chan, Michael, Cottam, Howard, Masliah, Eliezer
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683943/

Similar Items

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
by: Changyoun Kim, et al.
Published: (2018-08-01)

TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson’s Disease
by: Bender, Andreas, et al.
Published: (2013)

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson’s Disease
by: Rockenstein, Edward, et al.
Published: (2016)

ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
by: Spencer, Brian, et al.
Published: (2014)

Towards the total synthesis of hypoestoxide and dihypoestoxide
by: Cousin, Peggy
Published: (2017)

α‐synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease
by: Spencer, Brian, et al.
Published: (2016)

Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
by: Jennifer Ngolab, et al.
Published: (2017-06-01)

A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy
by: Spencer, Brian, et al.
Published: (2015)

Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies
by: Price, Diana L., et al.
Published: (2016)

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
by: Mandler, Markus, et al.
Published: (2015)

Non-cell-autonomous Neurotoxicity of α-synuclein Through Microglial Toll-like Receptor 2
by: Kim, Changyoun, et al.
Published: (2016)

Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
by: Valera, Elvira, et al.
Published: (2015)

Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson’s disease
by: Desplats, Paula, et al.
Published: (2012)

Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity
by: Fields, Jerel A., et al.
Published: (2016)

Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
by: Masliah, Eliezer, et al.
Published: (2011)

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
by: Rockenstein, Edward, et al.
Published: (2015)

The Temporal Expression Pattern of Alpha-Synuclein Modulates Olfactory Neurogenesis in Transgenic Mice
by: Schreglmann, Sebastian R., et al.
Published: (2015)

Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5 – implications for dementia with Lewy bodies
by: Overk, Cassia R, et al.
Published: (2014)

Role of Synucleins in Alzheimer’s Disease
by: Crews, Leslie, et al.
Published: (2009)

LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
by: Eun-Jin Bae, et al.
Published: (2018-08-01)

Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer
by: Fields, Jerel, et al.
Published: (2013)

A Novel Triple Repeat Mutant Tau Transgenic Model That Mimics Aspects of Pick’s Disease and Fronto-Temporal Tauopathies
by: Rockenstein, Edward, et al.
Published: (2015)

Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H ß-synuclein
by: Sekigawa, Akio, et al.
Published: (2012)

S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson’s disease
by: Sunico, Carmen R, et al.
Published: (2013)

Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
by: Xu, Jiqing, et al.
Published: (2016)

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
by: Rockenstein, Edward, et al.
Published: (2014)

Differential Effects of UCHL1 Modulation on Alpha-Synuclein in PD-Like Models of Alpha-Synucleinopathy
by: Cartier, Anna E., et al.
Published: (2012)

Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril
by: Kim, Changyoun, et al.
Published: (2016)

Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease
by: Crews, L, et al.
Published: (2011)

α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity
by: Hu, Zhaoyang, et al.
Published: (2016)

Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation
by: Vieira, Bruno Di Marco, et al.
Published: (2015)

Immunotherapy for Alzheimer’s disease: past, present and future
by: Spencer, Brian, et al.
Published: (2014)

Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model
by: Amschl, David, et al.
Published: (2013)

Preserved functional autonomic phenotype in adult mice overexpressing moderate levels of human alpha‐synuclein in oligodendrocytes
by: Tank, Jens, et al.
Published: (2014)

Impaired Baroreflex Function in Mice Overexpressing Alpha-Synuclein
by: Fleming, Sheila M., et al.
Published: (2013)

Alpha-Synuclein Function and Dysfunction on Cellular Membranes
by: Snead, David, et al.
Published: (2014)

Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease
by: Kaul, Tiffany, et al.
Published: (2011)

A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain
by: Fujita, Masayo, et al.
Published: (2010)

Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans
by: Chen, Shu G., et al.
Published: (2016)

Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons
by: Cabeza-Arvelaiz, Yofre, et al.
Published: (2011)